Showing results (91-100 of 447) with videos related to

Sort By:
Pageof 45
Cancer Informatics|November 28, 2022
Optimizing Drug Response Study Design in Patient-Derived Tumor XenograftsJessica Weiss, Nhu-An Pham, Melania Pintilie, et al.
Oncogene|May 5, 2005
Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progressionCathie Garnis, Jonathan J Davies, Timon P H Buys, et al.
Lung Cancer (Amsterdam, Netherlands)|August 18, 2020
PD-L1 lineage-specific quantification in malignant pleural effusions of lung adenocarcinoma by flow cytometryJu-Yoon Yoon, Rakesh Nayyar, Graeme Quest, et al.
Oncotarget|June 2, 2016
Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302Ines Lohse, Joanna Rasowski, Pinjiang Cao, et al.
Molecular and Cellular Biology|November 3, 2010
Global profiling and molecular characterization of alternative splicing events misregulated in lung cancerChristine M Misquitta-Ali, Edith Cheng, Dave O'Hanlon, et al.
Molecular Cancer Therapeutics|May 14, 2004
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancerPhillip J Gray, David J Bearss, Haiyong Han, et al.
Lung Cancer (Amsterdam, Netherlands)|December 21, 2012
Human papilloma virus genome is rare in North American non-small cell lung carcinoma patientsNaoki Yanagawa, Ami Wang, Derek Kohler, et al.
European Journal of Immunology|September 11, 2013
NKG2D regulates production of soluble TRAIL by ex vivo expanded human γδ T cellsPouneh Dokouhaki, Nicholas W Schuh, Betty Joe, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2012
Prognostic and predictive role of the VeriStrat plasma test in patients with advanced non-small-cell lung cancer treated with erlotinib or placebo in the NCIC Clinical Trials Group BR.21 trialDavid P Carbone, Keyue Ding, Heinrich Roder, et al.
Critical Reviews in Oncology/Hematology|May 30, 2024
Rediscovering immunohistochemistry in lung cancerAnna La Salvia, May-Lucie Meyer, Fred R Hirsch, et al.
Pageof 45